Author:
Mastrolia Salvatore Andrea,Mazor Moshe,Holcberg Gershon,Leron Elad,Beharier Ofer,Loverro Giuseppe,Erez Offer
Abstract
SummaryAccumulating evidence supports the concept of increased thrombin generation, placental vascular lesions, and inflammation as crucial points in the development of the great obstetrical syndromes [preeclampsia, intrauterine growth restriction (IUGR), preterm labor (PTL), preterm prelabor rupture of membranes (PROM), fetal demise and recurrent abortions]. In light of this, the role of heparins for primary or secondary prevention of these syndromes is becoming more and more apparent, mainly due to the antithrombotic and anti-inflammatory effects of heparins. There is agreement regarding the use of heparin in the prevention of gestational complications in patients with antiphospholipid syndrome, while its use for other obstetrical complications is under debate. In the present review we will describe the physiologic role of heparins on coagulation and inflammation and we will discuss current evidence regarding the use of heparins for the prevention/ treatment of obstetrical syndromes.
Reference107 articles.
1. Erez O, et al. The Activity of the Natural Initiator of Coagulation-Tissue Factor, But Not That of Its Pathway Inhibitor, is Elevated in Women with Preeclampsia and SGA: A Potential Explanation for the Excessive Thrombin Generation in These Syndromes. Annual Scientific Meeting of the Society for Gynecologic Investigation, Glasgow, Scotland, March 17-21, 2009. J Soc Gynecol Investig 2009. Poster presentation, Abstract 351
2. Low-Molecular-Weight Heparin for the Prevention of Obstetric Complications in Women with Thrombophilias
3. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia
4. Heparan sulfates and heparins: similar compounds performing the same functions in vertebrates and invertebrates?
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献